UK Launches Major Meningitis B Vaccination Program for Young People

Health authorities across the UK have announced a new, one-off vaccination program to protect about one million young people against meningitis B. This decision follows concerns about the largest and fastest-growing outbreak of the disease seen in the UK so far, which occurred in Kent earlier this year. Additionally, officials identified two other unusual clusters of cases in Weymouth, Dorset, and Reading, Berkshire. Together, these events resulted in the deaths of three young people, prompting the government to take immediate action.

According to the UK Health Security Agency (UKHSA), meningitis B bacteria are often carried in the nose and throat without causing harm. However, in some cases, the bacteria can cause serious infections, including meningitis—an infection of the membranes surrounding the brain and spinal cord—or blood poisoning. The NHS notes that up to one in ten cases of bacterial meningitis can be fatal. Those who survive the illness may face long-term health problems, such as hearing loss or epilepsy.

Health Secretary James Murray explained that the recent outbreaks suggest a possible change in how meningitis B affects the population. While officials continue to study the evidence, they decided to act now to protect those at the highest immediate risk. The program is specifically designed for students finishing their final year of school—Year 13 in England and Wales, Year 14 in Northern Ireland, and S6 in Scotland—as well as young people aged 18 to 25 who are starting university or moving into residential education for the first time this autumn.

Experts note that university students face a higher risk than many of their peers. This is due to several factors, including living in shared accommodation, attending parties, and having large social networks. These conditions make it easier for the bacteria to spread through close contact, such as kissing, sharing drinks, or using the same vapes. The UKHSA also pointed out that cases of this disease typically increase between October and November each year, making it important to provide protection before the new academic term begins.

This new program offers the Bexsero vaccine, which protects against most strains of meningitis B. It requires two doses, given at least 28 days apart. In England, the shots will be available through community pharmacies during July and August. Students will be contacted directly via the NHS app, text, email, or letter. For those starting university for the first time, appointments can be booked directly with pharmacies. International students under the age of 25 are also encouraged to receive their first dose before arriving in the UK, if possible.

While the UK has offered a different vaccine, known as MenACWY, to teenagers for years, it does not cover the B strain. Because of this, some parents previously paid for private vaccinations, which can cost £200 or more. The new government-funded program aims to remove this financial barrier. Caroline Temmink, the director of vaccination at NHS England, urged all eligible students to come forward for their doses to gain peace of mind before starting their studies.

The impact of this disease on families is profound. The BBC reported on the story of Aaron Mills, an 18-year-old student who died from meningitis in January 2026. His parents shared that they were confused when they learned of his diagnosis, as they believed he had been vaccinated. They later discovered that the vaccine he received as a child did not cover the specific strain that caused his illness. His mother described the pain of losing him as "unbearable," highlighting why health officials are now prioritizing this wider protection.

Each nation in the UK is managing the rollout slightly differently. In Wales, the program will run from July to December, with health boards contacting 17 and 18-year-olds directly. Similar efforts are beginning in Scotland and Northern Ireland. By providing these two doses before the autumn, health officials hope to reduce the risk of serious illness and prevent larger outbreaks as thousands of young people begin a new chapter in their lives.